RE:Lack of dosimetry tool linked to 4-5x over/under treatmentsThey seem to be doing everything they can to maximize the chances of a successful human trial.
"Doing it right" is trumping "doing it soon" every time the choice comes up.
If that means delays then so be it.
bencro wrote:
Dr. Lilge was mentioning at the AGM that the lack of a reliable dosimetry tool was responsible for over or under treatments in a ratio of 4-5x.
Watch specifically @07:38-07:45 ...
Theralase AGM 2016 - Dr. Lilge on the dosimetry advantages (@05:06-09:08)
Theralase engineers have developed the TLC-3200/TLC-3400 dosimetry tool that is capable of knowing the exact number of photons per surface area delivered to the bladder wall, in order to maximize the amount of drug delivered for the treatment.
That's what we call taking control on what matters the most in order to achieve the most optimal treatment and put all the chances on our side. Brilliant.